Solid Tumor Clinical Trials in Charleston, South Carolina
2 recruitingCharleston, South Carolina
Showing 1–2 of 2 trials
Recruiting
Phase 1Phase 2
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
Solid Tumor
Eisai Inc.182 enrolled58 locationsNCT04300556
Recruiting
Early Phase 1
Phase 0 Master Protocol for CIVO Intratumoral Microdosing of Anti-Cancer Therapies
Solid Tumor
Presage Biosciences15 enrolled12 locationsNCT04541108